Ocular Penetration of Topical Tacrolimus Eye Drops
Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
Investigators aim to evaluate the ocular penetration of topical tacrolimus 0.03% eye drops.
Topical tacrolimus 0.03% will be instilled into the eyes of patients 15 minutes before
cataract surgery. Aqueous samples will be collected at the time of cataract surgery and will
be subjected to detection of presence and level of tacrolimus.
Phase:
N/A
Details
Lead Sponsor:
The Eye Center and The Eye Foundation for Research in Ophthalmology